In addition to EC, TFF3 has previously been shown to enhance cell proliferation, survival, oncogenicity, invasion and metastasis of BC [17, 21], prostate cancer [29], cervical cancer [23] and hepatocellular carcinoma [48]. The gene discussed is TFF3; the disease is prostate carcinoma.